CLINICAL TRIALS PROFILE FOR ZYPREXA
✉ Email this page to a colleague
All Clinical Trials for Zyprexa
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000374 ↗ | Treatment for First-Episode Schizophrenia | Completed | National Institute of Mental Health (NIMH) | Phase 4 | 1998-09-01 | This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia. |
NCT00000374 ↗ | Treatment for First-Episode Schizophrenia | Completed | The Zucker Hillside Hospital | Phase 4 | 1998-09-01 | This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia. |
NCT00000374 ↗ | Treatment for First-Episode Schizophrenia | Completed | Northwell Health | Phase 4 | 1998-09-01 | This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Zyprexa
Condition Name
Clinical Trial Locations for Zyprexa
Trials by Country
Clinical Trial Progress for Zyprexa
Clinical Trial Phase
Clinical Trial Sponsors for Zyprexa
Sponsor Name